51 datasets found
  1. M

    Pharmacovigilance & Drug Safety Directors List (10,422+)

    • medicalprospects.com
    Updated Jul 30, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    MedicalProspects (2026). Pharmacovigilance & Drug Safety Directors List (10,422+) [Dataset]. https://medicalprospects.com/life-sciences-lab/pharma-biotech/pharmacovigilance-drug-safety-directors/
    Explore at:
    Dataset updated
    Jul 30, 2026
    Dataset authored and provided by
    MedicalProspects
    License

    https://medicalprospects.com/privacy-policy/https://medicalprospects.com/privacy-policy/

    Area covered
    United States and international
    Variables measured
    Function focus, Seniority level, Name and exact job title, Office phone where available, Optional add-on: technology data, Optional add-on: buyer intent signals, Professional email (verified before delivery), Organization name, type and parent organization, Organization address, city, state or region, country
    Description

    10,422+ Pharmacovigilance & Drug Safety Directors: covering Pharmaceutical company and Biotech company. Free 20-contact sample.

  2. v

    Global Pharmacovigilance Software Market Size By Application (Adverse Event...

    • verifiedmarketresearch.com
    Updated Feb 19, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    VERIFIED MARKET RESEARCH (2025). Global Pharmacovigilance Software Market Size By Application (Adverse Event Reporting Software, Drug Safety Audits Software), By Delivery Mode (On-premises, Cloud based), By End-User (Pharma and Biotech Companies, Contract Research Organizations (CROs)), By Geographic Scope And Forecast [Dataset]. https://www.verifiedmarketresearch.com/product/pharmacovigilance-software-market/
    Explore at:
    Dataset updated
    Feb 19, 2025
    Dataset authored and provided by
    VERIFIED MARKET RESEARCH
    License

    https://www.verifiedmarketresearch.com/privacy-policy/https://www.verifiedmarketresearch.com/privacy-policy/

    Time period covered
    2024 - 2031
    Area covered
    Global
    Description

    Pharmacovigilance software Market was valued at USD 206.62 Million in 2023 and is projected to reach USD 371.63 Million by 2031, growing at a CAGR of 7.66% from 2024 to 2031.

    Pharmacovigilance software Market Defination

    Pharmacovigilance software is a specialized tool designed to streamline and enhance the process of monitoring, detecting, assessing, and preventing adverse effects or any other drug-related problems. These systems support the collection, analysis, and reporting of data related to drug safety, ensuring compliance with regulatory requirements. Integration of various functionalities such as signal detection, risk management, and adverse event reporting, pharmacovigilance software helps pharmaceutical companies and regulatory authorities maintain comprehensive drug safety databases, facilitating prompt decision-making and improving patient safety.

  3. Ai-driven Drug Safety And Pharmacovigilance Platforms Market Growth Analysis...

    • technavio.com
    pdf
    Updated Apr 23, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Technavio (2026). Ai-driven Drug Safety And Pharmacovigilance Platforms Market Growth Analysis - Size and Forecast 2026-2030 [Dataset]. https://www.technavio.com/report/ai-driven-drug-safety-and-pharmacovigilance-platforms-market-industry-analysis
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Apr 23, 2026
    Dataset provided by
    TechNavio
    Authors
    Technavio
    License

    https://www.technavio.com/content/privacy-noticehttps://www.technavio.com/content/privacy-notice

    Time period covered
    2026 - 2030
    Description

    snapshot-tab-pane Ai-driven Drug Safety And Pharmacovigilance Platforms Market Size 2026-2030The ai-driven drug safety and pharmacovigilance platforms market size is valued to increase by USD 3.10 billion, at a CAGR of 19.9% from 2025 to 2030. Increasing volume and complexity of adverse event data will drive the ai-driven drug safety and pharmacovigilance platforms market.Major Market Trends & InsightsNorth America dominated the market and accounted for a 33.6% growth during the forecast period.By Deployment - Cloud-based platforms segment was valued at USD 951.5 million in 2024By End-user - Pharma and biotech companies segment accounted for the largest market revenue share in 2024Market Size & ForecastMarket Opportunities: USD 4.12 billionMarket Future Opportunities: USD 3.10 billionCAGR from 2025 to 2030 : 19.9%Market SummaryThe AI-driven drug safety and pharmacovigilance platforms market is undergoing a significant transformation, moving beyond reactive compliance to proactive, predictive safety management. This shift is fueled by the need to process vast volumes of unstructured data from sources like electronic health records, social media, and wearables.Advanced platforms leverage automated case processing and natural language processing for safety to automate routine tasks, allowing pharmacovigilance teams to focus on strategic analysis and risk mitigation. For instance, a pharmaceutical company launching a new therapy can deploy machine learning signal detection models to monitor real-world evidence in near real-time.This capability enables the rapid identification of potential adverse drug reaction monitoring, ensuring quicker updates to safety protocols and enhancing patient outcomes. The adoption of such intelligent pharmacovigilance systems not only ensures regulatory compliance but also builds a more resilient and efficient drug safety ecosystem, ultimately driving better public health protection through robust pharmacovigilance technology solutions and adverse event monitoring.What will be the Size of the Ai-driven Drug Safety And Pharmacovigilance Platforms Market during the forecast period? Get Key Insights on Market Forecast (PDF) Get Free SampleHow is the Ai-driven Drug Safety And Pharmacovigilance Platforms Market Segmented?The ai-driven drug safety and pharmacovigilance platforms industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.DeploymentCloud-based platformsOn-premises solutionsHybrid deployment modelsEnd-userPharma and biotech companiesContract research organizationsRegulatory authoritiesHealthcare providersApplicationAdverse event detectionRisk managementLiterature screeningRegulatory complianceGeographyNorth AmericaUSCanadaMexicoEuropeGermanyUKFranceAPACChinaIndiaJapanMiddle East and AfricaSaudi ArabiaUAEIsraelSouth AmericaBrazilArgentinaColombiaRest of World (ROW)By Deployment InsightsThe cloud-based platforms segment is estimated to witness significant growth during the forecast period.Cloud-based platforms are reshaping pharmacovigilance through scalable, flexible software-as-a-service models. This deployment minimizes on-site hardware and maintenance, enabling GxP compliant cloud platforms to deliver continuous updates and refinements to machine learning signal detection algorithms.Organizations benefit from a unified, accessible environment for global safety teams, improving data processing efficiency by up to 40%.The model facilitates seamless real-world evidence integration and supports AI-driven benefit-risk assessment by providing the computational power needed for complex AI-powered literature screening.This approach, centered on pharmacovigilance process optimization, shifts spending from capital to operational expenditures, making advanced pharmacovigilance automation technologies accessible to a broader range of organizations. The focus on AI for regulatory submissions and intelligent automation in pharmacovigilance is paramount. Get Free SampleThe Cloud-based platforms segment was valued at USD 951.5 million in 2024 and showed a gradual increase during the forecast period. Get Free SampleRegional AnalysisNorth America is estimated to contribute 33.6% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. See How Ai-driven Drug Safety And Pharmacovigilance Platforms Market Demand is Rising in North America Get Free SampleThe geographic landscape of the AI-driven drug safety market is led by North America, which accounts for over 33% of incremental growth due to its ad

  4. F

    Pharmacovigilance and Drug Safety Software Market By Functionality (ADR...

    • fnfresearch.com
    pdf
    Updated Oct 31, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Facts and Factors (2026). Pharmacovigilance and Drug Safety Software Market By Functionality (ADR Reporting, Drug Safety Audits, Issue Tracking, & Fully Integrated Software), By Delivery Mode (On-Premise & On-Demand), By End-User (Pharma & Biotech Companies, CROs, BPOs, & Others), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2026 [Dataset]. https://www.fnfresearch.com/pharmacovigilance-and-drug-safety-software-market-report
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Oct 31, 2026
    Dataset authored and provided by
    Facts and Factors
    License

    https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy

    Time period covered
    2022 - 2030
    Area covered
    Global
    Description

    [187+ Pages Report] Global pharmacovigilance and drug safety software market share is growing with a CAGR of 5.9% to a projected value of USD 205.9 Million by 2026.

  5. Z

    Pharmacovigilance and Drug Safety Software Market 2024 To 2033

    • datasetcatalog.nlm.nih.gov
    • zenodo.org
    Updated Jun 30, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    (2024). Pharmacovigilance and Drug Safety Software Market 2024 To 2033 [Dataset]. http://doi.org/10.5281/zenodo.14603014
    Explore at:
    Dataset updated
    Jun 30, 2024
    Description

    Pharmacovigilance and Drug Safety Software Market Size, Trends and Insights By Functionality (Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software), By Delivery Mode (On-premises, Cloud-based), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033. Reports Description The Global Pharmacovigilance and Drug Safety Software Market is projected to grow significantly from 2024 to 2033, driven by the increasing need for efficient adverse event reporting and regulatory compliance in the pharmaceutical industry. This market encompasses software solutions designed to monitor, detect, assess, and prevent adverse effects of pharmaceutical products, ensuring patient safety and regulatory adherence. Pharmacovigilance and drug safety software encompasses specialized computer programs designed to optimize the monitoring, analysis, and reporting of adverse drug reactions (ADRs) and other drug-related safety concerns. These software systems are integral to pharmacovigilance, a field focused on ensuring the safe and effective use of medications. They enable pharmaceutical companies, regulatory authorities, and healthcare professionals to efficiently collect, manage, and analyze extensive data on drug safety. Additionally, these solutions aid in identifying potential risks and patterns, allowing for timely interventions and the implementation of risk mitigation strategies. For more information, DOWNLOAD FREE SAMPLE Now at https://www.custommarketinsights.com/request-for-free-sample/?reportid=51659

  6. w

    Global Pharmacovigilance and Drug Safety Software Market Research Report: By...

    • wiseguyreports.com
    Updated Aug 27, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    WiseGuy Research Consultants Pvt Ltd (2026). Global Pharmacovigilance and Drug Safety Software Market Research Report: By Application (Adverse Event Reporting, Risk Management, Compliance Management, Data Management, Signal Detection), By Deployment Type (On-premise, Cloud-based, Hybrid), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Regulatory Authorities), By Functionality (Data Entry, Data Analysis, Case Management, Reporting) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) | Includes: Vendor Assessment, Technology Impact Analysis, Partner Ecosystem Mapping & Competitive Index - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/pharmacovigilance-and-drug-safety-software-market
    Explore at:
    Dataset updated
    Aug 27, 2026
    Dataset authored and provided by
    WiseGuy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    2026 - 2035
    Area covered
    Global
    Variables measured
    CAGR, Base Year, Market Size, Key Companies, Delivery Format, Forecast Period, Regions Covered, Segments Covered, Historical Period, Forecast Market Size
    Description

    The Pharmacovigilance and Drug Safety Software Market was valued at USD 2 Billion in 2025 and is projected to grow to USD 5.8 Billion by 2035, at a CAGR of 8.8%. Pharmacovigilance And Drug Safety Software Market Overview: Pharmacovigilance and Drug Safety Software Market Overview: The Pharmacovigilance and Drug Safety Software Market Size was valued at 2,300 USD Million in 2024. The Pharmacovigilance and Drug Safety Software Market is expected to grow from 2,500 USD Million in 2025 to 5.8 USD Billion by 2035. The Pharmacovigilance and Drug Safety Software Market CAGR (growth rate) is expected to be around 8.8% during the forecast period (2025 - 2035). Key Pharmacovigilance and Drug Safety Software Market Trends Highlighted The Global Pharmacovigilance and Drug Safety Software Market is witnessing significant trends driven by the increasing importance of drug safety and regulatory compliance. The rise in adverse drug reactions and the subsequent demand for effective monitoring tools have catalyzed investments in pharmacovigilance software. Key market drivers include the growing focus on patient safety and the regulatory requirements established by global entities. Organizations are increasingly adopting automated solutions to streamline the reporting and monitoring processes, which enhances efficiency and accuracy in drug safety management. There are numerous opportunities to explore within this sector.The integration of artificial intelligence and machine learning into pharmacovigilance systems presents a promising avenue for innovation. These technologies can enhance data analysis capabilities and predictive modeling, thereby improving risk assessment and management outcomes. Additionally, the global shift towards personalized medicine creates a demand for targeted safety monitoring solutions, positioning companies that specialize in customizable software favorably in the market. Recent trends indicate a surge in cloud-based pharmacovigilance solutions, providing flexibility and scalability for pharmaceutical companies and regulatory agencies worldwide.The capacity to manage large datasets and collaborate in real-time is becoming essential, especially as regulatory bodies emphasize transparency and accessibility. Moreover, with governments globally pushing for enhanced monitoring of drug safety, there is a mounting urgency for compliance, further driving the adoption of advanced pharmacovigilance software. As the market anticipates a substantial growth trajectory, it is clear that investing in innovative solutions will be crucial for stakeholders aiming to remain competitive in this evolving landscape. Source: Primary Research, Secondary Research, WGR Database and Analyst Review Pharmacovigilance and Drug Safety Software Market Segment Insights: Pharmacovigilance and Drug Safety Software Market Regional Insights The regional landscape of the Global Pharmacovigilance and Drug Safety Software Market exhibits a dynamic growth pattern, with North America holding a majority share due to its advanced healthcare infrastructure and regulatory frameworks. Valued at 843 USD Million in 2024, this region is projected to increase significantly to 2,094 USD Million by 2035. Europe also reflects strong growth potential, driven by stringent regulations and a high emphasis on patient safety, while the Asia Pacific region showcases moderate increase attributed to the rising adoption of technology in healthcare.In the Middle East and Africa, there is steady expansion resulting from increasing awareness of drug safety and emerging pharmaceutical markets. Meanwhile, South America is witnessing gradual growth, spurred by improving healthcare policies and a focus on patient-centric solutions. These distinct regional developments are shaping the overall market dynamics as various segments respond to the pressing need for improved pharmacovigilance practices and drug safety measures across healthcare systems globally. Source: Primary Research, Secondary Research, WGR Database and Analyst Review • North America : North America leads in pharmacovigilance software developments driven by advancements in AI and Io

  7. Pharmacovigilance And Drug Safety Software Market By Functionality (Adverse...

    • verifiedmarketresearch.com
    Updated Sep 6, 2024
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    VERIFIED MARKET RESEARCH (2024). Pharmacovigilance And Drug Safety Software Market By Functionality (Adverse Event Reporting Software, Signal Management Software), Deployment Mode (On-Premise, On-Demand), End-User (Pharma and Biotech Companies, Contract Research Organizations (CROS)), & Region for 2024-2031 [Dataset]. https://www.verifiedmarketresearch.com/product/global-pharmacovigilance-and-drug-safety-software-market-size-and-forecast/
    Explore at:
    Dataset updated
    Sep 6, 2024
    Dataset provided by
    Verified Market Researchhttps://www.verifiedmarketresearch.com/
    Authors
    VERIFIED MARKET RESEARCH
    License

    https://www.verifiedmarketresearch.com/privacy-policy/https://www.verifiedmarketresearch.com/privacy-policy/

    Time period covered
    2024 - 2031
    Area covered
    Global
    Description

    Pharmacovigilance and Drug Safety Software Market size was valued at USD 9.33 Billion in 2024 and is projected to reach USD 20.01 Billion by 2031, growing at a CAGR of 11.04% from 2024 to 2031

    Global Pharmacovigilance And Drug Safety Software Market Drivers

    Rising Incidence of Adverse Drug Reactions (ADRs): The increasing prevalence of adverse drug reactions and medication errors underscores the importance of pharmacovigilance and drug safety measures. Pharmacovigilance software enables efficient detection, recording, and analysis of adverse events, helping pharmaceutical companies and healthcare organizations mitigate risks and enhance patient safety.

    Growing Pharmaceutical Industry: The pharmaceutical industry is experiencing rapid growth due to factors such as population aging, increasing chronic diseases, and expanding healthcare access in emerging markets. As the pharmaceutical industry expands, the demand for pharmacovigilance and drug safety software also grows to support the safety monitoring of a growing number of drugs and medical products.

    Increasing Adoption of Electronic Health Records (EHRs): The widespread adoption of electronic health records (EHRs) in healthcare settings creates opportunities for integrating pharmacovigilance and drug safety software with existing health information systems. Integrated solutions streamline data capture, enhance interoperability, and facilitate comprehensive patient safety monitoring across healthcare settings.

    Increasing Focus on Pharmacovigilance Outsourcing: Pharmaceutical companies are increasingly outsourcing pharmacovigilance activities to specialized service providers to reduce costs, enhance operational efficiency, and access specialized expertise. Pharmacovigilance software solutions play a crucial role in supporting pharmacovigilance outsourcing by providing collaborative platforms, remote access, and secure data exchange capabilities.

    Globalization of Clinical Trials: Pharmaceutical companies conduct clinical trials in diverse geographic regions to support drug development and regulatory approval processes. Pharmacovigilance software enables global pharmacovigilance and safety monitoring by providing centralized data management, multilingual support, and compliance with international pharmacovigilance regulations.

  8. m

    Clinical Trials, Data Warehouse, Drug Safety, Pharmacovigilance, eTMF...

    • data.mendeley.com
    Updated Apr 5, 2022
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    bleap1 bleap digital (2022). Clinical Trials, Data Warehouse, Drug Safety, Pharmacovigilance, eTMF Software/IT Solutions for Pharma, Biotech and life Sciences CROs in Bangalore, India, USA & Europe [Dataset]. http://doi.org/10.17632/tft7gvtj7w.1
    Explore at:
    Dataset updated
    Apr 5, 2022
    Authors
    bleap1 bleap digital
    License

    Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
    License information was derived automatically

    Area covered
    India, Bengaluru
    Description

    Clinevotech ODCMS Inc., a customized software solutions company specialized in clinical trials, data warehousing, drug safety , eTMF (electronic trial master file) for Pharma and life sciences companies, in Bangalore India providing Software Development For Pharmaceutical Manufacturers (ODCMS) to clients Worldwide.

  9. c

    Pharmacovigilance and Drug Safety Software Market Analysis 2026: Revenue,...

    • cognitivemarketresearch.com
    pdf,excel,csv,ppt
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Cognitive Market Research and Consulting, Pharmacovigilance and Drug Safety Software Market Analysis 2026: Revenue, Volume, Market Size, Share, CAGR, Growth Trends, Competitor Analysis, Historic Data, and Forecast to 2034 [Dataset]. https://www.cognitivemarketresearch.com/pharmacovigilance-and-drug-safety-software-market-report
    Explore at:
    pdf,excel,csv,pptAvailable download formats
    Dataset authored and provided by
    Cognitive Market Research and Consulting
    License

    https://www.cognitivemarketresearch.com/privacy-policyhttps://www.cognitivemarketresearch.com/privacy-policy

    Time period covered
    2022 - 2034
    Area covered
    Global
    Variables measured
    Africa CAGR 2025-2033, Europe CAGR 2025-2033, Global CAGR 2025-2033, Africa Market Size 2021, Africa Market Size 2025, Africa Market Size 2033, Europe Market Size 2021, Europe Market Size 2025, Europe Market Size 2033, Global Market Size 2021, and 162 more
    Description

    Executive Summary of Pharmacovigilance and Drug Safety Software Market The global Pharmacovigilance and Drug Safety Software market is on a robust growth trajectory, projected to expand from $173.355 million in 2021 to $375.503 million by 2033, reflecting a compound annual growth rate (CAGR) of 6.653%. This expansion is primarily fueled by increasingly stringent regulatory mandates for drug safety monitoring and reporting across the globe. The rising volume of adverse drug reaction (ADR) data, stemming from increased pharmaceutical consumption and a growing pipeline of new drugs, necessitates advanced software solutions for efficient data management and analysis. Technological advancements, particularly the integration of artificial intelligence and cloud computing, are transforming the landscape by enhancing automation and scalability. North America currently dominates the market, but the Asia-Pacific region is emerging as the fastest-growing market, driven by its expanding pharmaceutical industry and improving healthcare infrastructure. The market's evolution is geared towards more predictive, automated, and integrated systems to ensure patient safety and regulatory compliance. Key strategic insights from our comprehensive analysis reveal:

    North America maintains a commanding lead in the market, driven by its advanced healthcare infrastructure, the presence of major pharmaceutical companies, and stringent FDA regulations. However, its growth rate is slightly below the global average. The Asia-Pacific region is poised for the most rapid growth, with the highest regional CAGR. This is attributed to the burgeoning pharmaceutical and biotech sectors in countries like China and India, coupled with increasing outsourcing of pharmacovigilance activities to the region. The adoption of next-generation technologies such as Artificial Intelligence (AI), machine learning (ML), and cloud-based platforms is a critical trend. These technologies are pivotal for automating adverse event case processing, enhancing signal detection, and improving the overall efficiency and accuracy of drug safety monitoring.

    Strategic Recommendations for Manufacturers Manufacturers should prioritize the development of cloud-native, AI-driven platforms that offer end-to-end solutions, from automated case intake to advanced signal analytics. Focusing on user-centric design to simplify complex workflows and ensuring seamless interoperability with EMR/EHR systems and other data sources is crucial. It is also recommended to offer scalable and modular pricing models to cater to the needs of a diverse client base, including small biotech firms and large CROs. Expanding into high-growth Asia-Pacific markets through strategic partnerships and localizing solutions to meet regional regulatory nuances will be key to capturing future growth. Market Dynamics of Pharmacovigilance Drug Safety Software Market

    Key Drivers for Pharmacovigilance Drug Safety Software Market

    Increasing Regulatory Pressure and Compliance Requirements to Boost Market Growth

    The rising stringency of global regulatory frameworks from agencies such as the FDA (US), EMA (Europe), and PMDA (Japan) has become a major catalyst for the adoption of pharmacovigilance drug safety software. These agencies require pharmaceutical and biotechnology companies to systematically collect, analyze and report adverse drug reactions (ADRs) and safety-related data throughout a product's lifecycle. Non-compliance can lead to severe penalties, market withdrawals, or reputational damage. As a result, companies are seeking automated and efficient pharmacovigilance solutions that can support end-to-end regulatory compliance. Modern safety software offers standardized reporting formats, real-time signal detection, and integration with global databases such as EudraVigilance and FAERS. This enhances transparency, reduces human error, and accelerates data submission. For instance, PegBio selected the LifeSphere MultiVigilance product from ArisGlobal to transition their pharmacovigilance from contract research organization (CRO) services to in-house practices with this leading pharmacovigilance software. This helped the company to strengthen their inhouse pharmacovigilance and drug safety solutions and led to saving of funds.

    https://www.arisglobal.com/media/press-release/chinas-pegbio-selects-lifesphere-by-arisglobal-for-safety-case-processing/

    Growing Volume of Adverse Event Data and Complex Drug Po...

  10. Z

    Pharmacovigilance and Drug Safety Software Market by Functionality (ADR...

    • zionmarketresearch.com
    pdf
    Updated Oct 29, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Zion Market Research (2026). Pharmacovigilance and Drug Safety Software Market by Functionality (ADR Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software), by Delivery Mode (On-Premises and On-Demand), by End-User (Pharma & Biotech Companies, Contract Research Organizations (CROS), Business Process Outsourcing (BPO) Firms, and Other Pharmacovigilance Service Providers), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032 [Dataset]. https://www.zionmarketresearch.com/report/pharmacovigilance-drug-safety-software-market
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Oct 29, 2026
    Dataset authored and provided by
    Zion Market Research
    License

    https://www.zionmarketresearch.com/privacy-policyhttps://www.zionmarketresearch.com/privacy-policy

    Time period covered
    2022 - 2030
    Area covered
    Global
    Description

    The global Pharmacovigilance and Drug Safety Software Market size was USD 200.5 Mn in 2023 & rise to USD 370.48 Mn by 2032 at a CAGR of 7.06%.

  11. w

    Global Drug Safety Pharmacovigilance PV Software Market Research Report: By...

    • wiseguyreports.com
    Updated Aug 27, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    WiseGuy Research Consultants Pvt Ltd (2026). Global Drug Safety Pharmacovigilance PV Software Market Research Report: By Type (Cloud-Based Solutions, On-Premise Solutions, Web-Based Solutions), By Functionality (Case Processing, Adverse Event Reporting, Risk Management), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations), By Deployment (Software as a Service, Installed Software, Hybrid Solutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) | Includes: Vendor Assessment, Technology Impact Analysis, Partner Ecosystem Mapping & Competitive Index - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/drug-safety-pharmacovigilance-pv-software-market
    Explore at:
    Dataset updated
    Aug 27, 2026
    Dataset authored and provided by
    WiseGuy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    2026 - 2035
    Area covered
    Global
    Variables measured
    CAGR, Base Year, Market Size, Key Companies, Delivery Format, Forecast Period, Regions Covered, Segments Covered, Historical Period, Forecast Market Size
    Description

    The Drug Safety Pharmacovigilance PV Software Market was valued at USD 2263.7 Million in 2025 and is projected to grow to USD 4500 Million by 2035, at a CAGR of 7.1%. Drug Safety Pharmacovigilance Pv Software Market Overview: The Drug Safety Pharmacovigilance PV Software Market Size was valued at 2,113.7 USD Million in 2024. The Drug Safety Pharmacovigilance PV Software Market is expected to grow from 2,263.7 USD Million in 2025 to 4,500 USD Million by 2035. The Drug Safety Pharmacovigilance PV Software Market CAGR (growth rate) is expected to be around 7.1% during the forecast period (2025 - 2035). Key Drug Safety Pharmacovigilance Pv Software Market Trends Highlighted The Global Drug Safety Pharmacovigilance (PV) Software Market is witnessing significant trends driven by the increasing focus on patient safety and regulatory compliance. As the global pharmaceutical sector evolves, stringent regulations established by bodies such as the World Health Organization and regional health authorities have pushed companies to adopt advanced PV software solutions for monitoring drug safety. This emphasis on real-time reporting and data management enhances transparency and ensures timely detection of adverse drug reactions. An impressive opportunity lies in the rising demand for cloud-based PV solutions. These technologies allow for seamless data integration and improve accessibility, which is increasingly crucial as more organizations move towards remote operations post-pandemic.Moreover, the integration of artificial intelligence and machine learning into PV software is reshaping the industry, presenting avenues to enhance data analysis and automate routine tasks, thereby increasing operational efficiency. Recent trends also reveal a growing focus on patient-centric approaches, where organizations prioritize real-world evidence and patient feedback to inform their safety monitoring processes. This shift aligns with global initiatives to foster patient engagement in healthcare decisions, potentially leading to improved outcomes and higher satisfaction levels. Strategic collaborations between technology providers and pharmaceutical companies further enhance capabilities in drug safety monitoring.Overall, the Global Drug Safety Pharmacovigilance Software Market is evolving with robust technological advancements and a clear emphasis on regulatory compliance, presenting numerous opportunities for innovations and improved methodologies in drug safety management, expected to contribute to a market size of 4500.0 million USD by 2035. Source: Primary Research, Secondary Research, WGR Database and Analyst Review Drug Safety Pharmacovigilance Pv Software Market Segment Insights: Drug Safety Pharmacovigilance Pv Software Market Regional Insights The Global Drug Safety Pharmacovigilance PV Software Market displays a diverse landscape across various regions, with North America holding the majority share, valued at 1,040 USD Million in 2024 and expected to reach 2,100 USD Million by 2035. This region is driven by advanced healthcare infrastructure and stringent regulatory mandates, leading to a robust demand for effective drug safety monitoring solutions. Europe is experiencing steady expansion, bolstered by legislative frameworks emphasizing patient safety and product efficacy, contributing significantly to the overall market growth.The APAC region is witnessing moderate increase, fueled by rising pharmaceutical activity and improved healthcare standards, while South America is also observing gradual growth, reflecting an emerging focus on pharmacovigilance in response to increasing drug-related safety concerns. The MEA is characterized by a more challenging environment, facing gradual decline, yet there remains a potential for growth as regional regulatory bodies enhance their oversight capabilities. Overall, the regional dynamics indicate a strong varying progression, influenced by regulatory policies, healthcare accessibility, and technological advancements within the pharmaceutical sector. Source: Primary Research, Secondary Research, WGR Database and Analyst Review North America : North America is witnessin

  12. w

    Global Drug Safety Pharmacovigilance Solution Market Research Report: By...

    • wiseguyreports.com
    Updated Aug 27, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    WiseGuy Research Consultants Pvt Ltd (2026). Global Drug Safety Pharmacovigilance Solution Market Research Report: By Solution Type (Software, Service, Consulting), By Deployment Type (Cloud-Based, On-Premises, Hybrid), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations), By Functionality (Adverse Event Reporting, Data Management, Risk Management) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) | Includes: Vendor Assessment, Technology Impact Analysis, Partner Ecosystem Mapping & Competitive Index - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/drug-safety-pharmacovigilance-solution-market
    Explore at:
    Dataset updated
    Aug 27, 2026
    Dataset authored and provided by
    WiseGuy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    2026 - 2035
    Area covered
    Global
    Variables measured
    CAGR, Base Year, Market Size, Key Companies, Delivery Format, Forecast Period, Regions Covered, Segments Covered, Historical Period, Forecast Market Size
    Description

    The Drug Safety Pharmacovigilance Solution Market was valued at USD 5.67 Billion in 2025 and is projected to grow to USD 10.2 Billion by 2035, at a CAGR of 6%. Drug Safety Pharmacovigilance Solution Market Overview: The Drug Safety Pharmacovigilance Solution Market Size was valued at 5.35 USD Billion in 2024. The Drug Safety Pharmacovigilance Solution Market is expected to grow from 5.67 USD Billion in 2025 to 10.2 USD Billion by 2035. The Drug Safety Pharmacovigilance Solution Market CAGR (growth rate) is expected to be around 6.0% during the forecast period (2025 - 2035). Key Drug Safety Pharmacovigilance Solution Market Trends Highlighted The Global Drug Safety Pharmacovigilance Solution Market is experiencing several key trends driven primarily by the increasing emphasis on patient safety and regulatory compliance. One of the major market drivers is the growing incidence of adverse drug reactions, leading regulatory authorities worldwide to mandate robust pharmacovigilance systems. This regulatory pressure has pushed pharmaceutical companies to seek comprehensive solutions that ensure safety monitoring and risk assessment processes are in place. Digitalization in the healthcare sector is another trend that is facilitating the implementation of advanced pharmacovigilance systems, as organizations increasingly leverage automation, AI, and data analytics to streamline their processes. Opportunities in the global market are abundant, particularly in emerging economies where healthcare systems are evolving. There is a rising demand for effective pharmacovigilance solutions among local pharmaceutical companies aiming to enhance their operational capabilities and meet international standards. The expansion of clinical trials in these regions also opens avenues for integrated solutions designed to monitor drug safety more effectively. Additionally, as the industry shifts towards personalized medicine, pharmacovigilance solutions that can handle diverse datasets and individualized treatment responses become more vital. Recent trends indicate a focus on enhancing collaboration between regulatory bodies and pharmaceutical companies, fostering more transparent communication channels to ensure public trust.The adoption of cloud-based systems is also noteworthy, as it allows for greater scalability in managing pharmacovigilance activities globally. This shift towards connected systems exemplifies the ongoing transformation in the industry, aligning with global initiatives to prioritize health outcomes and safety standards, setting a promising trajectory for the market as it approaches projected revenue milestones in the coming years. Source: Primary Research, Secondary Research, WGR Database and Analyst Review Drug Safety Pharmacovigilance Solution Market Segment Insights: Drug Safety Pharmacovigilance Solution Market Regional Insights The Global Drug Safety Pharmacovigilance Solution Market exhibits significant regional segmentation, with North America holding the majority share due to its advanced healthcare infrastructure and regulatory frameworks that promote drug safety. In 2024, North America was valued at 2,300 USD Million and is expected to reach 4,150 USD Million by 2035, highlighting robust growth driven by increasing regulatory requirements and technological advancements. Meanwhile, Europe demonstrates steady expansion in the Drug Safety Pharmacovigilance Solution Market, bolstered by supportive governmental policies and a strong emphasis on patient safety.The APAC region is experiencing moderate increases, driven by rising healthcare investments and a growing focus on drug efficacy monitoring. South America shows gradual growth as well, with pharmaceutical companies increasingly recognizing the importance of pharmacovigilance. Lastly, the Middle East and Africa (MEA) present a developing landscape for pharmacovigilance solutions, with efforts to improve healthcare systems and regulatory compliance. Overall, regional dynamics are influenced by local regulatory environments, technological advancements, and the commitment to ensuring public health safety. Source: Primary Research, Sec

  13. G

    Pharmacovigilance AI Market Research Report 2033

    • growthmarketreports.com
    csv, pdf, pptx
    Updated Aug 22, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Growth Market Reports (2025). Pharmacovigilance AI Market Research Report 2033 [Dataset]. https://growthmarketreports.com/report/pharmacovigilance-ai-market
    Explore at:
    pdf, csv, pptxAvailable download formats
    Dataset updated
    Aug 22, 2025
    Dataset authored and provided by
    Growth Market Reports
    Time period covered
    2024 - 2032
    Area covered
    Global
    Description

    Pharmacovigilance AI Market Size and Growth Outlook



    Worldwide, the Pharmacovigilance AI market size in 2024 stands at USD 1.7 billion, reflecting the growing adoption of artificial intelligence in drug safety monitoring and adverse event detection. The market is projected to expand at a robust CAGR of 29.3% from 2025 to 2033, reaching a forecasted value of USD 14.8 billion by 2033. This significant growth is attributed to the increasing complexity of pharmacovigilance processes, the rising volume of adverse event reports, and the need for efficient, scalable, and accurate data analysis tools powered by AI.




    The primary growth driver for the Pharmacovigilance AI market is the exponential increase in pharmaceutical and biotechnology product launches, which has led to a surge in the volume and complexity of safety data that must be processed. Traditional pharmacovigilance methods, which rely heavily on manual review and reporting, are no longer sufficient to handle this data deluge. AI technologies, including natural language processing, machine learning, and deep learning, are being increasingly deployed to automate adverse event detection, streamline signal management, and enhance risk analysis. These AI-powered solutions not only improve the accuracy and timeliness of safety assessments but also significantly reduce operational costs for pharmaceutical companies and regulatory agencies, thereby driving market growth.




    Another key factor fueling market expansion is the tightening of global regulatory requirements for drug safety and post-market surveillance. Regulatory bodies such as the FDA, EMA, and other regional authorities are mandating more comprehensive and proactive pharmacovigilance practices, compelling market players to invest in advanced AI-enabled systems. The integration of AI in pharmacovigilance enables real-time monitoring of adverse events, automated literature screening, and effective management of large-scale safety databases. This regulatory push, combined with the increasing focus on patient safety, is prompting pharmaceutical, biotechnology companies, and contract research organizations to adopt AI-based pharmacovigilance platforms at an accelerated pace.




    The rapid digital transformation across the healthcare and life sciences sector is also contributing to the growth of the Pharmacovigilance AI market. The proliferation of electronic health records, wearable devices, and digital health platforms has resulted in the generation of vast amounts of real-world data, which can be harnessed by AI algorithms for more comprehensive safety surveillance. Furthermore, advances in cloud computing and data integration technologies are making it easier for organizations to deploy scalable, interoperable, and secure pharmacovigilance solutions. As the industry continues to embrace digitalization, the adoption of AI-driven pharmacovigilance is expected to intensify, creating substantial opportunities for technology providers and service vendors.




    From a regional perspective, North America currently leads the Pharmacovigilance AI market, driven by strong regulatory frameworks, high healthcare IT adoption, and significant investments in AI research and development. Europe follows closely, supported by stringent pharmacovigilance regulations and collaborative initiatives between industry and regulatory agencies. The Asia Pacific region is poised for the highest growth rate over the forecast period, fueled by the expansion of the pharmaceutical industry, increasing clinical trial activity, and growing awareness of drug safety. Latin America and the Middle East & Africa are also witnessing steady growth, albeit from a smaller base, as governments and healthcare organizations prioritize drug safety and regulatory compliance.





    Pharmacovigilance AI Market by Component



    The Pharmacovigilance AI market is segmented by component into Software and Services, each playing a crucial role in the overall ecosystem. The software segment

  14. F

    Pharmacovigilance Outsourcing Market Size, Share, Growth Analysis Report By...

    • fnfresearch.com
    pdf
    Updated Sep 25, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Facts and Factors (2026). Pharmacovigilance Outsourcing Market Size, Share, Growth Analysis Report By Service (Pre-marketing Pharmacovigilance Services, Post-marketing Pharmacovigilance Services, and Others), By Provider (Contract Research Organizations, Business Process Outsourcing), By End-User (Pharmaceutical Companies, Biotechnology Companies, and Others), and By Region - Global Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2026-2034 [Dataset]. https://www.fnfresearch.com/pharmacovigilance-outsourcing-market-size
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Sep 25, 2026
    Dataset authored and provided by
    Facts and Factors
    License

    https://www.fnfresearch.com/privacy-policyhttps://www.fnfresearch.com/privacy-policy

    Time period covered
    2022 - 2030
    Area covered
    Global
    Description

    Pharmacovigilance outsourcing market size was valued at USD 5.75 Bn in 2025 and is projected to reach USD 12.12 Bn by 2034, growing at a CAGR of 8.6% from 2026 to 2034.

  15. b

    Derived biotech safety-and-event intelligence API: openFDA adverse events,...

    • brickroad.network
    Updated Oct 15, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Pharma Signal (2026). Derived biotech safety-and-event intelligence API: openFDA adverse events, enforcement recalls and drug labels fused with SEC EDGAR filings, exposed as computed outputs rather than raw records — composite drug risk scores (0-1) with explainable breakdowns, PRR/ROR pharmacovigilance signals with Evans' criteria classification, therapeutic-class benchmarks, monthly adverse-event trend series with anomaly flags, a regulatory ledger, drug-to-company-to-ticker entity resolution, and AI-generated analyst briefs [Dataset]. https://brickroad.network/public-index/pharma-signal.com/derived-biotech-safety-and-event-intelligence-api-openfda
    Explore at:
    Dataset updated
    Oct 15, 2026
    Dataset authored and provided by
    Pharma Signal
    Area covered
    UK, US, Europe
    Description

    Pharma Signal — Derived biotech safety-and-event intelligence API: openFDA adverse events, enforcement recalls and drug labels fused with SEC EDGAR filings, exposed as computed outputs rather than raw records — composite drug risk scores (0-1) with explainable breakdowns, PRR/ROR pharmacovigilance signals with Evans' criteria classification, therapeutic-class benchmarks, monthly adverse-event trend series with anomaly flags, a regulatory ledger, drug-to-company-to-ticker entity resolution, and AI-generated analyst briefs. Small, early and technically credible: 1M+ reports distilled to 358 dru…

  16. w

    Global Drug Safety and Pharmacovigilance Solution Market Research Report: By...

    • wiseguyreports.com
    Updated Aug 27, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    WiseGuy Research Consultants Pvt Ltd (2026). Global Drug Safety and Pharmacovigilance Solution Market Research Report: By Solution Type (Software Solutions, Consulting Services, Database Solutions, Others), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Government Agencies), By Deployment Type (On-Premise, Cloud-Based, Hybrid), By Functionality (Adverse Event Reporting, Risk Management, Data Mining, Regulatory Compliance) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) | Includes: Vendor Assessment, Technology Impact Analysis, Partner Ecosystem Mapping & Competitive Index - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/drug-safety-and-pharmacovigilance-solution-market
    Explore at:
    Dataset updated
    Aug 27, 2026
    Dataset authored and provided by
    WiseGuy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    2026 - 2035
    Area covered
    Global
    Variables measured
    CAGR, Base Year, Market Size, Key Companies, Delivery Format, Forecast Period, Regions Covered, Segments Covered, Historical Period, Forecast Market Size
    Description

    The Drug Safety and Pharmacovigilance Solution Market was valued at USD 4.59 Billion in 2025 and is projected to grow to USD 10.5 Billion by 2035, at a CAGR of 8.6%. Drug Safety And Pharmacovigilance Solution Market Overview: The Drug Safety and Pharmacovigilance Solution Market Size was valued at 4,230 USD Million in 2024. The Drug Safety and Pharmacovigilance Solution Market is expected to grow from 4,590 USD Million in 2025 to 10.5 USD Billion by 2035. The Drug Safety and Pharmacovigilance Solution Market CAGR (growth rate) is expected to be around 8.6% during the forecast period (2025 - 2035). Key Drug Safety And Pharmacovigilance Solution Market Trends Highlighted The Global Drug Safety and Pharmacovigilance Solution Market is experiencing significant growth driven by the increasing need for drug safety monitoring and regulatory compliance. As pharmaceutical companies face rising scrutiny from regulatory bodies across different regions, the demand for effective pharmacovigilance solutions has risen. This is complemented by advancements in technology, such as artificial intelligence and big data analytics, which are enhancing the efficiency and accuracy of drug safety reporting. Additionally, the growing incidence of adverse drug reactions and the resultant need to ensure patient safety are pivotal in shaping market demand.There are numerous opportunities to be explored in the Global market, particularly for innovative solutions that integrate real-time data analysis and streamline reporting processes. Companies that invest in the development of integrated platforms that provide comprehensive pharmacovigilance services stand to gain a competitive edge. The shift towards personalized medicine is also creating avenues for tailored safety monitoring solutions, as drug safety protocols become increasingly specific to individual patient profiles. In recent times, trends such as the establishment of global pharmacovigilance collaborations and initiatives focusing on post-marketing surveillance have gained traction.Regulatory authorities are emphasizing the importance of robust safety assessment frameworks, propelling the integration of digital solutions that can assess drug safety on a global scale. Furthermore, with the continuous evolution of regulations across various jurisdictions, there is a growing push for harmonization in reporting practices, leading to a more standardized approach in drug safety. These emerging trends highlight an ever-evolving landscape that is poised for substantial growth, with a projected market size of 10.5 billion USD by the year 2035. Source: Primary Research, Secondary Research, WGR Database and Analyst Review Drug Safety And Pharmacovigilance Solution Market Segment Insights: Drug Safety And Pharmacovigilance Solution Market Regional Insights The Global Drug Safety and Pharmacovigilance Solution Market is characterized by a diverse regional landscape, with North America holding the majority with a valuation of 2,100 USD Million in 2024 and projected to reach 4,750 USD Million by 2035. This region's prominence can be attributed to stringent regulatory frameworks, advanced healthcare infrastructure, and robust investment in Research and Development. Europe follows with steady expansion, driven by increasing compliance requirements and a strong emphasis on patient safety. The APAC region is experiencing moderate growth, largely due to the rising adoption of pharmacovigilance practices and increasing clinical trial activities.South America shows gradual growth propelled by emerging market opportunities and an expanding pharmaceutical sector. Meanwhile, the Middle East and Africa are seeing a moderate increase in market share, influenced by an evolving healthcare landscape and growing awareness about drug safety. The overall trends across these regions reflect a growing commitment to enhancing drug safety practices and improving patient outcomes, which are critical in navigating the complex regulatory environment of the healthcare industry. Source: Primary Research, Secondary Research, WGR Database and Analyst Review North America : The Drug Safety and Pharmacov

  17. G

    Signal Detection Solutions in Pharmacovigilance Market Research Report 2033

    • growthmarketreports.com
    csv, pdf, pptx
    Updated Aug 22, 2025
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Growth Market Reports (2025). Signal Detection Solutions in Pharmacovigilance Market Research Report 2033 [Dataset]. https://growthmarketreports.com/report/signal-detection-solutions-in-pharmacovigilance-market
    Explore at:
    csv, pdf, pptxAvailable download formats
    Dataset updated
    Aug 22, 2025
    Dataset authored and provided by
    Growth Market Reports
    Time period covered
    2024 - 2032
    Area covered
    Global
    Description

    Signal Detection Solutions in Pharmacovigilance Market Outlook



    According to our latest research, the global market size for Signal Detection Solutions in Pharmacovigilance was valued at USD 1.37 billion in 2024. The market is expected to grow at a robust CAGR of 12.8% from 2025 to 2033, reaching an anticipated value of USD 4.13 billion by 2033. This significant growth trajectory is largely driven by increasing regulatory requirements, the rising volume of adverse event data, and the rapid adoption of advanced analytics and artificial intelligence in pharmacovigilance processes.




    The primary growth factor for the Signal Detection Solutions in Pharmacovigilance market is the escalating complexity of drug safety monitoring in the face of expanding pharmaceutical and biotechnology pipelines. With the global pharmaceutical industry witnessing a surge in novel drug launches, the need for robust pharmacovigilance systems to identify, assess, and mitigate potential risks has never been greater. Signal detection solutions are gaining traction as they enable organizations to efficiently sift through vast datasets, identifying patterns and emerging safety signals that traditional methods may overlook. This shift is further bolstered by regulatory agencies worldwide, which are increasingly mandating proactive surveillance and reporting, compelling industry players to invest in advanced signal detection technologies.




    Another pivotal driver is the integration of artificial intelligence and machine learning algorithms into pharmacovigilance platforms. These technologies significantly enhance the ability to process and analyze large volumes of adverse event reports, social media data, and real-world evidence, leading to earlier identification of safety signals. The adoption of cloud-based solutions has further democratized access to sophisticated analytics, enabling even smaller organizations to implement comprehensive pharmacovigilance systems. As a result, the market is witnessing a paradigm shift from reactive to proactive safety monitoring, with companies leveraging predictive analytics to anticipate and mitigate risks before they escalate into major safety concerns.




    Additionally, the globalization of clinical trials and the increasing participation of emerging markets in drug development are contributing to the growth of the Signal Detection Solutions in Pharmacovigilance market. As pharmaceutical companies expand their operations across diverse geographies, they face the challenge of managing heterogeneous data sources and complying with varying regulatory frameworks. Signal detection solutions equipped with multilingual and multi-regional capabilities are becoming indispensable tools for ensuring compliance and maintaining a consistent standard of patient safety worldwide. This trend is expected to accelerate as more countries strengthen their pharmacovigilance regulations in alignment with international standards.




    From a regional perspective, North America currently dominates the global market, accounting for the largest share in 2024, driven by the presence of major pharmaceutical companies, stringent regulatory frameworks, and early adoption of advanced technologies. Europe follows closely, benefiting from harmonized regulatory guidelines and strong emphasis on patient safety. The Asia Pacific region is emerging as a lucrative market, fueled by the rapid growth of the pharmaceutical sector, increasing regulatory oversight, and rising awareness about pharmacovigilance. Latin America and the Middle East & Africa, while still nascent, are expected to witness steady growth as healthcare infrastructure and regulatory maturity improve.





    Component Analysis



    The Signal Detection Solutions in Pharmacovigilance market is segmented by component into software and services, each playing a critical role in the overall ecosystem. The software segment dominates the market, accounting for a substantial share in 2024, owing to the growing need for automation and data

  18. Z

    Markt für Pharmakovigilanz- und Arzneimittelsicherheitssoftware nach...

    • zionmarketresearch.com
    pdf
    Updated Oct 10, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Zion Market Research (2026). Markt für Pharmakovigilanz- und Arzneimittelsicherheitssoftware nach Funktionalität (ADR-Meldesoftware, Software für Arzneimittelsicherheitsaudits, Problemverfolgungssoftware und vollständig integrierte Software), nach Bereitstellungsmodus (vor Ort und auf Abruf), nach Endbenutzer (Pharma- und Biotechunternehmen, Auftragsforschungsinstitute (CROS), Unternehmen für Business Process Outsourcing (BPO) und andere Pharmakovigilanzdienstleister) und nach Region – Globaler und regionaler Branchenüberblick, Marktinformationen, umfassende Analysen, historische Daten und Prognosen 2024–2032 [Dataset]. https://www.zionmarketresearch.com/de/report/pharmacovigilance-drug-safety-software-market
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Oct 10, 2026
    Dataset authored and provided by
    Zion Market Research
    License

    https://www.zionmarketresearch.com/privacy-policyhttps://www.zionmarketresearch.com/privacy-policy

    Time period covered
    2022 - 2030
    Area covered
    Global
    Description

    Der globale Markt für Software zur Pharmakovigilanz und Arzneimittelsicherheit hatte im Jahr 2023 ein Volumen von 200.5 Millionen US-Dollar und wird bis 2032 auf 370.48 Millionen US-Dollar ansteigen, was einer durchschnittlichen jährlichen Wachstumsrate von 7.06 % entspricht.

  19. w

    Global Pharmacovigilance PV and Drug Safety Software Market Research Report:...

    • wiseguyreports.com
    Updated Feb 22, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    WiseGuy Research Consultants Pvt Ltd (2026). Global Pharmacovigilance PV and Drug Safety Software Market Research Report: By Software Type (Case Processing, Signal Detection, Pharmacovigilance Compliance, Risk Management, Data Analytics), By Deployment Type (On-Premises, Cloud-Based, Hybrid), By End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Regulatory Authorities), By Functionality (Adverse Event Reporting, Regulatory Compliance, Data Management, Real-Time Monitoring) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) | Includes: Vendor Assessment, Technology Impact Analysis, Partner Ecosystem Mapping & Competitive Index - Forecast to 2035 [Dataset]. https://www.wiseguyreports.com/reports/pharmacovigilance-pv-and-drug-safety-software-market
    Explore at:
    Dataset updated
    Feb 22, 2026
    Dataset authored and provided by
    WiseGuy Research Consultants Pvt Ltd
    License

    https://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy

    Time period covered
    2026 - 2035
    Area covered
    Global
    Variables measured
    CAGR, Base Year, Market Size, Key Companies, Delivery Format, Forecast Period, Regions Covered, Segments Covered, Historical Period, Forecast Market Size
    Description

    The Pharmacovigilance PV and Drug Safety Software Market was valued at USD 4.71 Billion in 2025 and is projected to grow to USD 10 Billion by 2035, at a CAGR of 7.8%. Pharmacovigilance Pv And Drug Safety Software Market Overview: The Pharmacovigilance PV and Drug Safety Software Market Size was valued at 4,370 USD Million in 2024. The Pharmacovigilance PV and Drug Safety Software Market is expected to grow from 4,710 USD Million in 2025 to 10 USD Billion by 2035. The Pharmacovigilance PV and Drug Safety Software Market CAGR (growth rate) is expected to be around 7.8% during the forecast period (2025 - 2035). Key Pharmacovigilance Pv And Drug Safety Software Market Trends Highlighted The Global Pharmacovigilance (PV) and Drug Safety Software Market is experiencing significant trends driven by increasing regulatory requirements and the need for efficient monitoring of drug safety. Rapid advancements in technology, such as artificial intelligence and machine learning, are shaping the way companies manage drug safety data, allowing for real-time analytics and improved decision-making processes. Regulatory agencies worldwide are placing greater emphasis on reporting adverse effects, thus pushing pharmaceutical companies to adopt sophisticated PV solutions. These regulatory frameworks highlight the importance of ensuring patient safety, thereby increasing demand for comprehensive PV software.Moreover, the urgent need to capture and analyze large volumes of data presents numerous opportunities for market players. As the drug development process becomes more globalized, companies are seeking to enhance their pharmacovigilance capabilities across multiple regions, leading to a growing interest in cloud-based solutions. Continued investments in research and development activities by pharmaceutical firms can enable them to stay compliant with evolving regulations and improve their safety reporting practices. In recent times, there has been an uptick in collaboration between pharmaceutical companies and software developers to enhance drug safety systems.This trend is vital as it fosters innovation, resulting in more robust solutions that can streamline the PV process. The increasing awareness of the benefits associated with drug safety software is leading to higher adoption rates, particularly in emerging markets, where regulatory bodies are also tightening control over drug safety. Overall, the evolving landscape of regulatory requirements and technological advancements is crucial in shaping the future of the Global Pharmacovigilance PV and Drug Safety Software Market. Source: Primary Research, Secondary Research, WGR Database and Analyst Review Pharmacovigilance Pv And Drug Safety Software Market Segment Insights: Pharmacovigilance Pv And Drug Safety Software Market Regional Insights The Regional insights of the Global Pharmacovigilance PV and Drug Safety Software Market reveal a diverse landscape with North America standing out as the leading sector, valued at 2,000 USD Million in 2024 and anticipated to grow to 4,200 USD Million by 2035, clearly dominating the market. This region benefits from advanced technological infrastructure and stringent regulatory requirements, driving the need for efficient pharmacovigilance solutions. Europe demonstrates steady expansion in this market, bolstered by a well-established healthcare system and robust regulatory framework that emphasize patient safety.The APAC region shows promising prospects, supported by increasing investments in healthcare infrastructure and rising awareness about drug safety, indicating a strong growth trajectory. South America is experiencing moderate increase due to gradual improvements in healthcare access and regulatory frameworks, while the MEA region is witnessing a subtle rise, driven by increasing healthcare spending and a growing emphasis on drug safety practices. These regional trends indicate the varying demands for pharmacovigilance software, influenced by regional regulations, healthcare systems, and technological advancements. Source: Primary Research, Secondary Research, WGR Database and Analyst Review North America : The No

  20. Z

    Marché des logiciels de pharmacovigilance et de sécurité des médicaments par...

    • zionmarketresearch.com
    pdf
    Updated Sep 26, 2026
    Share
    FacebookFacebook
    TwitterTwitter
    Email
    Click to copy link
    Link copied
    Close
    Cite
    Zion Market Research (2026). Marché des logiciels de pharmacovigilance et de sécurité des médicaments par fonctionnalité (logiciels de déclaration des effets indésirables, logiciels d'audit de sécurité des médicaments, logiciels de suivi des problèmes et logiciels entièrement intégrés), par mode de livraison (sur site et à la demande), par utilisateur final (sociétés pharmaceutiques et biotechnologiques, organismes de recherche sous contrat (CROS), entreprises d'externalisation des processus métier (BPO) et autres prestataires de services de pharmacovigilance) et par région - Aperçu mondial et régional du secteur, informations sur le marché, analyse complète, données historiques et prévisions 2024-2032 [Dataset]. https://www.zionmarketresearch.com/fr/report/pharmacovigilance-drug-safety-software-market
    Explore at:
    pdfAvailable download formats
    Dataset updated
    Sep 26, 2026
    Dataset authored and provided by
    Zion Market Research
    License

    https://www.zionmarketresearch.com/privacy-policyhttps://www.zionmarketresearch.com/privacy-policy

    Time period covered
    2022 - 2030
    Area covered
    Global
    Description

    La taille du marché mondial des logiciels de pharmacovigilance et de sécurité des médicaments était de 200.5 millions USD en 2023 et devrait atteindre 370.48 millions USD d'ici 2032 à un TCAC de 7.06 %.

Share
FacebookFacebook
TwitterTwitter
Email
Click to copy link
Link copied
Close
Cite
MedicalProspects (2026). Pharmacovigilance & Drug Safety Directors List (10,422+) [Dataset]. https://medicalprospects.com/life-sciences-lab/pharma-biotech/pharmacovigilance-drug-safety-directors/

Pharmacovigilance & Drug Safety Directors List (10,422+)

Explore at:
Dataset updated
Jul 30, 2026
Dataset authored and provided by
MedicalProspects
License

https://medicalprospects.com/privacy-policy/https://medicalprospects.com/privacy-policy/

Area covered
United States and international
Variables measured
Function focus, Seniority level, Name and exact job title, Office phone where available, Optional add-on: technology data, Optional add-on: buyer intent signals, Professional email (verified before delivery), Organization name, type and parent organization, Organization address, city, state or region, country
Description

10,422+ Pharmacovigilance & Drug Safety Directors: covering Pharmaceutical company and Biotech company. Free 20-contact sample.

Search
Clear search
Close search
Google apps
Main menu